News | September 05, 2023
Neuroscientist Abhijeet Satani unveils Cognitively Operated System in Ahmedabad
The cognitively operated system is a mother patent invention, first launched in India
The cognitively operated system is a mother patent invention, first launched in India
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
Carbidopa and Levodopa is used to treat symptoms of Parkinson's disease or Parkinson-like symptoms
Amantadine Extended-Release capsules had annual sales of US $2.7 million in the United States according to IQVIA data
This dense phase often resembles liquid droplets exhibiting higher protein density and weaker molecular motion than the surrounding medium.
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
Groundbreaking collaborative research program will explore common characteristics of glaucoma, alzheimer's
It includes multiple studies demonstrating that post-translational modifications of conformational variants of p53 are associated with the pathogenesis of Alzheimer's Disease
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
AbbVie to present 30 abstracts demonstrating its leadership in neuroscience, including continued migraine treatment research across the spectrum of the disease, commitment to patients with advanced Parkinson's disease, and new studies in spasticity and cervical dystonia
Subscribe To Our Newsletter & Stay Updated
